Neogen (NEOG) Share-based Compensation Growth (5y) (2015 - 2026)
Neogen (NEOG) Share-based Compensation Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Neogen | 2.61 Bn | 2.42 Bn | 107.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 12.51% |
| Feb 28, 2026 | -5.37% |
| Nov 30, 2025 | 23.27% |
| Aug 31, 2025 | 23.86% |
| May 31, 2025 | 43.81% |
| Feb 28, 2025 | 20.69% |
| Nov 30, 2024 | 24.39% |
| Aug 31, 2024 | 20.99% |
| May 31, 2024 | -56.46% |
| Feb 29, 2024 | 23.49% |
| Nov 30, 2023 | 20.19% |
| Aug 31, 2023 | 13.21% |
| May 31, 2023 | -51.60% |
| Feb 28, 2023 | 22.54% |
| Nov 30, 2022 | 15.83% |
| Aug 31, 2022 | 6.34% |
| May 31, 2022 | 9.68% |
| Feb 28, 2022 | 9.10% |
| Nov 30, 2021 | 43.13% |
| Aug 31, 2021 | 3.94% |